170 related articles for article (PubMed ID: 7848592)
1. Octreotide therapy of large-volume refractory AIDS-associated diarrhea: a randomized controlled trial.
Garcia Compean D; Ramos Jimenez J; Guzman de la Garza F; Saenz C; Maldonado H; Barragan RF; Michel H
AIDS; 1994 Nov; 8(11):1563-7. PubMed ID: 7848592
[TBL] [Abstract][Full Text] [Related]
2. Effect of octreotide on refractory AIDS-associated diarrhea. A prospective, multicenter clinical trial.
Cello JP; Grendell JH; Basuk P; Simon D; Weiss L; Wittner M; Rood RP; Wilcox CM; Forsmark CE; Read AE
Ann Intern Med; 1991 Nov; 115(9):705-10. PubMed ID: 1929038
[TBL] [Abstract][Full Text] [Related]
3. Multicenter trial of octreotide in patients with refractory acquired immunodeficiency syndrome-associated diarrhea.
Simon DM; Cello JP; Valenzuela J; Levy R; Dickerson G; Goodgame R; Brown M; Lyche K; Fessel WJ; Grendell J
Gastroenterology; 1995 Jun; 108(6):1753-60. PubMed ID: 7768380
[TBL] [Abstract][Full Text] [Related]
4. Octreotide treatment in secretory and cyrptosporidial diarrhea in patients with acquired immunodeficiency syndrome (AIDS): clinical evaluation.
Liberti A; Bisogno A; Izzo E
J Chemother; 1992 Oct; 4(5):303-5. PubMed ID: 1479420
[TBL] [Abstract][Full Text] [Related]
5. Octreotide in the management of chemoradiotherapy-induced diarrhea refractory to loperamide in patients with rectal carcinoma.
Topkan E; Karaoglu A
Oncology; 2006; 71(5-6):354-60. PubMed ID: 17873499
[TBL] [Abstract][Full Text] [Related]
6. Octreotide acetate in refractory bone marrow transplant-associated diarrhea.
Crouch MA; Restino MS; Cruz JM; Perry JJ; Hurd DD
Ann Pharmacother; 1996 Apr; 30(4):331-6. PubMed ID: 8729883
[TBL] [Abstract][Full Text] [Related]
7. Octreotide versus loperamide in the treatment of fluorouracil-induced diarrhea: a randomized trial.
Cascinu S; Fedeli A; Fedeli SL; Catalano G
J Clin Oncol; 1993 Jan; 11(1):148-51. PubMed ID: 8418225
[TBL] [Abstract][Full Text] [Related]
8. Subcutaneous octreotide versus oral loperamide in the treatment of diarrhea following chemotherapy.
Gebbia V; Carreca I; Testa A; Valenza R; Curto G; Cannata G; Borsellino N; Latteri MA; Cipolla C; Florena M
Anticancer Drugs; 1993 Aug; 4(4):443-5. PubMed ID: 8400346
[TBL] [Abstract][Full Text] [Related]
9. Treatment of secretory diarrhea in AIDS with the somatostatin analogue SMS 201-995.
Füessl HS; Zoller WG; Kochen MM; Bogner JR; Heinrich B; Matuschke A; Goebel FD
Klin Wochenschr; 1989 Apr; 67(8):452-5. PubMed ID: 2724869
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of diarrhea with loperamide in palliative medicine. A systematic review].
Pastrana T; Meißner W
Schmerz; 2013 Apr; 27(2):182-9. PubMed ID: 23475156
[TBL] [Abstract][Full Text] [Related]
11. The efficacy of octreotide in the therapy of acute radiation-induced diarrhea: a randomized controlled study.
Yavuz MN; Yavuz AA; Aydin F; Can G; Kavgaci H
Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):195-202. PubMed ID: 12182992
[TBL] [Abstract][Full Text] [Related]
12. Resolution of refractory chemotherapy-induced diarrhea (CID) with octreotide long-acting formulation in cancer patients: 11 case studies.
Rosenoff S
Support Care Cancer; 2004 Aug; 12(8):561-70. PubMed ID: 15160318
[TBL] [Abstract][Full Text] [Related]
13. Randomized trial of loperamide versus dose escalation of octreotide acetate for chemotherapy-induced diarrhea in bone marrow transplant and leukemia patients.
Geller RB; Gilmore CE; Dix SP; Lin LS; Topping DL; Davidson TG; Holland HK; Wingard JR
Am J Hematol; 1995 Nov; 50(3):167-72. PubMed ID: 7485077
[TBL] [Abstract][Full Text] [Related]
14. Octreotide in the treatment of refractory diarrhea.
Fried M
Digestion; 1999; 60 Suppl 2():42-6. PubMed ID: 10207230
[TBL] [Abstract][Full Text] [Related]
15. Octreotide for symptomatic treatment of diarrhea due to cytomegalovirus colitis.
Bartels MC; Mergenhagen KA
Ann Pharmacother; 2011 Jan; 45(1):e4. PubMed ID: 21189368
[TBL] [Abstract][Full Text] [Related]
16. Octreotide long-acting formulation (LAR) in chronic loperamide-refractory diarrhea not related to cancer treatment.
Mystakidou K; Katsouda E; Tsilika E; Smyrniotis V; Vassiliou I; Tsiatas M; Vlahos L
Anticancer Res; 2006; 26(3B):2325-8. PubMed ID: 16821610
[TBL] [Abstract][Full Text] [Related]
17. Pilot study of sandostatin (octreotide) therapy of refractory HIV-associated diarrhea.
Fanning M; Monte M; Sutherland LR; Broadhead M; Murphy GF; Harris AG
Dig Dis Sci; 1991 Apr; 36(4):476-80. PubMed ID: 2007364
[TBL] [Abstract][Full Text] [Related]
18. Control of irinotecan-induced diarrhea by octreotide after loperamide failure.
Barbounis V; Koumakis G; Vassilomanolakis M; Demiri M; Efremidis AP
Support Care Cancer; 2001 Jun; 9(4):258-60. PubMed ID: 11430421
[TBL] [Abstract][Full Text] [Related]
19. A double blind, randomized, placebo-controlled phase II study to assess the safety and efficacy of orally administered SP-303 for the symptomatic treatment of diarrhea in patients with AIDS.
Holodniy M; Koch J; Mistal M; Schmidt JM; Khandwala A; Pennington JE; Porter SB
Am J Gastroenterol; 1999 Nov; 94(11):3267-73. PubMed ID: 10566728
[TBL] [Abstract][Full Text] [Related]
20. Successful management of intractable cryptosporidial diarrhea with intravenous octreotide, a somatostatin analogue.
Kreinik G; Burstein O; Landor M; Bernstein L; Weiss LM; Wittner M
AIDS; 1991 Jun; 5(6):765-7. PubMed ID: 1883548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
